Literature DB >> 8407727

An autopsy case of intracranial hemorrhage during tissue plasminogen activator infusion.

H Masuoka1, H Kotani, T Yazu, O Mizuno, M Miyahara, K Sekoguchi, R Tanaka, K Ueda, A Fukui, Y Futagami.   

Abstract

We describe an autopsy case of severe intracranial hemorrhage which occurred during the infusion of tissue plasminogen activator (t-PA) for acute myocardial infarction. A 75-year-old man was admitted with substernal chest pain of 3-h duration and electrocardiographic changes consistent with an acute inferior myocardial infarction. Physical examination was unremarkable, except for an initial blood pressure reading of 160/96 mmHg. The patient received 3,000 IU intravenous heparin followed by a 2.4 x 10(6) IU bolus dose of tissue plasminogen activator (t-PA) (Alteplase). This was followed by a drip infusion of 21.6 x 10(6) IU of t-PA over 1 h (total dose 41 mg). Thirty minutes after the infusion of t-PA was initiated, the patient suddenly lost consciousness and began to have violent convulsions, followed by cardiac arrest. Autopsy revealed massive hemorrhage in the bilateral cerebrum and brain stem. To our knowledge, this is the first case of sudden death during t-PA infusion therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407727     DOI: 10.1007/bf01744802

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  7 in total

Review 1.  Coronary thrombolysis--it's worth the risk.

Authors:  A J Tiefenbrunn; P A Ludbrook
Journal:  JAMA       Date:  1989-04-14       Impact factor: 56.272

2.  Neurological complications after thrombolytic treatment for acute myocardial infarction: emphasis on unprecedented manifestations.

Authors:  P Caramelli; E G Mutarelli; B Caramelli; B Tranchesi; F Pileggi; M Scaff
Journal:  Acta Neurol Scand       Date:  1992-05       Impact factor: 3.209

3.  Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.

Authors:  C S Kase; M S Pessin; J A Zivin; G J del Zoppo; A J Furlan; J W Buckley; R G Snipes; J K LittleJohn
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

4.  Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.

Authors:  U Tebbe; P Tanswell; E Seifried; W Feuerer; K H Scholz; K S Herrmann
Journal:  Am J Cardiol       Date:  1989-09-01       Impact factor: 2.778

5.  Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Authors:  J M Gore; M Sloan; T R Price; A M Randall; E Bovill; D Collen; S Forman; G L Knatterud; G Sopko; M L Terrin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

6.  Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.

Authors:  S E Carlson; M S Aldrich; H S Greenberg; E J Topol
Journal:  Arch Neurol       Date:  1988-10

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Authors:  A K Rao; C Pratt; A Berke; A Jaffe; I Ockene; T L Schreiber; W R Bell; G Knatterud; T L Robertson; M L Terrin
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.